Medical devices, healthcare technology and the business of care
510(k) clearance · K260289

Perfect-O Ostial Positioning Catheter

Balosmark, Inc. · Decision date Jun 5, 2026

FDA DECISIONK260289

What did the FDA decide?

FDA records K260289 as a 510(k) premarket notification, with a decision dated Jun 5, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Jun 5, 2026

FDA source record

Regulatory record facts

Identifier
K260289
Regulatory pathway
510(k) premarket notification
Product code
DQY
Decision code
SESE
Decision date
Jun 5, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Percutaneous.

Product code
DQY
FDA device class
2

FDA decision timeline

  1. K260289 received

    Application receipt date recorded by FDA.

  2. K260289 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code DQY

Product / regulatory recordCompanyPathwayDecision dateSource
Vantis Vascular, Inc.510(k) clearanceSep 18, 2026FDA
NHanceITK260559
IMDS Operation B.V.510(k) clearanceAug 14, 2026FDA
Alembic, LLC510(k) clearanceAug 12, 2026FDA
CenterPoint Systems, LLC510(k) clearanceJul 29, 2026FDA
CenterPoint Systems, LLC510(k) clearanceJul 29, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Balosmark, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Kalamazoo, MI

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records